SCHEMBL24093249

SCHEMBL24093249

FC(F)(F)Sc1cccc(CN2CCCCC2)c1

nearest known ligand 0.61

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.61
▸ KDM4E B2RXH2 2/20 0.61
▸ GAA P10253 1/20 0.61
▸ SMN1; SMN2 Q16637 3/20 0.58
▸ TDP1 Q9NUW8 1/20 0.54
▸ PRMT6 Q96LA8 1/20 0.51
▸ CYP2D6 P10635 2/20 0.49
▸ CYP2C9 P11712 1/20 0.49
▸ HIF1A Q16665 1/20 0.49
▸ UBE2M P61081 1/20 0.48
▸ DCUN1D1 Q96GG9 1/20 0.48
▸ HTT P42858 1/20 0.47
▸ CYP2C19 P33261 1/20 0.46
▸ HRH3 Q9Y5N1 3/20 0.46
▸ POLB P06746 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24093254 0.81 HRH3 (0.62) ALDH1A1KDM4EGAASMN1; SMN2CYP2D6
SCHEMBL24093437 0.80 ALDH1A1 (0.47) ALDH1A1KDM4EGAASMN1; SMN2TDP1
SCHEMBL13574521 0.80 ALDH1A1 (0.58) ALDH1A1KDM4EGAASMN1; SMN2TDP1
SCHEMBL11339852 0.78 PRMT6 (0.78) ALDH1A1KDM4EGAASMN1; SMN2TDP1
SCHEMBL11192726 0.78 PRMT6 (0.78) ALDH1A1KDM4EGAASMN1; SMN2TDP1
SCHEMBL13800970 0.78 PRMT6 (0.57) ALDH1A1KDM4EGAASMN1; SMN2TDP1
SCHEMBL7813997 0.77 SMN1; SMN2 (0.55) ALDH1A1KDM4EGAASMN1; SMN2TDP1
SCHEMBL30341002 0.76 ALDH1A1 (1.00) ALDH1A1KDM4EGAASMN1; SMN2TDP1
SCHEMBL4235961 0.76 ALDH1A1 (1.00) ALDH1A1KDM4EGAASMN1; SMN2TDP1
SCHEMBL24093309 0.76 ALDH1A1 (0.44) ALDH1A1KDM4EGAASMN1; SMN2UBE2M

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3452464-B1 PYRAZOLE DERIVATIVES, COMPOSITIONS AND THERAPEUTIC USE THEREOF HOFFMANN LA ROCHE (CH) 2021-12-15 — — EP disclosed
Send feedback